ArticleScientific reports2026
Semantic embedding of variant effect annotations enables rapid and accurate pathogenicity prediction with VUS.Life.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Interpreting the pathogenicity of genetic variants remains a critical bottleneck in genomic medicine. Millions of variants of uncertain significance (VUS) hinder the clinical application of genetic findings. Traditional computational approaches often rely on hand-engineered features and fail to capture the complexity of multidimensional genomic annotations fully. We developed VUS.Life, a multi-modal framework that synergizes semantic text embeddings of biological and clinical annotations with protein language modeling. We transformed variant annotations from Variant Effect Predictor (VEP) into natural language descriptions which are then converted into vector embeddings via established Large Language Models (LLMs), namely all- mpnet-base-v2, MedEmbed-large-v0.1, and text-embedding-004. Pathogenicity of a variant of interest is predicted by its proximity in the vector embedding space with variants of known pathogenicity. We further extended VUS.Life by employing residue-level delta embeddings from the ESMC-600 M model to capture both clinical context and biophysical constraints. We evaluated the framework on > 10,000 variants across eight ACMG Tier 1 disease genes (BRCA1, BRCA2, FBN1, ATM, PALB2, MYH7, USH2A, and PAH), achieving Leave-One-Out Cross-Validation (LOO-CV) MCC of 0.895-0.989 and F1 ≥ 0.94 across all genes evaluated. Additionally, our unsupervised FBN1 structural analysis using ESMC-600M revealed that delta embeddings disentangled distinct pathogenic mechanisms, topologically separating disulfide bond disruptions from calcium- binding defects. These structural clusters correlated strongly with Zero-Shot Log-Likelihood Ratio (LLR) scores, validating evolutionary fitness as a proxy for pathogenicity. An ablation study removing all pre-computed pathogenicity scores demonstrated that MPNet embeddings retain full discriminative power, confirming that the classifier captures biological signal independent of existing scoring tools. This semantic embedding framework, VUS.Life, accurately captures pathogenicity-relevant features from complex variant annotations, enabling robust automated classification across eight ACMG Tier 1 disease genes and three embedding models. The approach generalizes beyond well-curated genes and supports scalable, interpretable, and representation-based classification of VUS. It holds significant promise for alleviating the variant interpretation bottleneck in clinical genomics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.